Se fundamentó el concepto y el tratamiento de la Hipertensión arterial sistólica aislada con bases bibliográficas europeas, americanas y latinoamericanas, apoyados en guías prácticas clínicas para el diagnóstico y tratamiento.
A través de la ficha de recolección de datos de las historias clínicas, se pudo determinar las variantes más frecuentes en el diagnóstico
de la patología y la terapéutica utilizada en el servicio de cardiología en el hospital José María Velasco Ibarra.
El protocolo propuesto es una guía dirigida al personal médico, en la cual se diagnostica a un paciente con hipertensión arterial sistólica aislada y se establece el tratamiento basado en los recursos disponibles y existentes en el Hospital José María Velasco Ibarra y en el sistema de salud en Ecuador.
RECOMENDACIONES
Poner en ejecución el protocolo de manejo para el control de tensión arterial sistólica en pacientes con hipertensión sistólica aislada, dirigido al personal de salud en el servicio de cardiología del hospital José María Velasco Ibarra.
El personal de salud deberá utilizar los recursos terapéuticos y diagnósticos disponibles en el cuadro básico de salud para el control adecuado de la tensión arterial sistólica en pacientes con hipertensión arterial sistólica aislada en el hospital José María Velasco Ibarra de la ciudad del Tena.
BIBLIOGRAFÍA
Allhat Officers and Coordinators for the Allhat Collaborative Research Group. (2002). The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme i. Jama.
Appel, L. J., Espeland, M. A., & Easter, L. (2001). Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med.
Applegate, W. B., Davis, B. R., & Black, H. R. (1991). Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc.
Arch, C. (2003). Encuesta Nacional de Salud. (G. d. Chile, Ed.) Chile: Ministerio de Salud.
Aronow, W. S., Fleg, J. L., & Pepine, C. J. (2011). ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Beckett, N. S., Peters, R., & Fletcher, A. E. (2008). Treatment of hypertension in patients 80 years of age or older. N Engl J Med. Blood Pressure Lowering Treatment Trialists' Colla, Turnbull, F., & Neal, B.
(2008). Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ.
Boutitie, F., Gueyffier, F., & Pocock, S. (2002). J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med.
Burt, V. L., Whelton, P., & Roccella, E. J. (1995). Prevalence of hypertension in the US adult population. Results from the Third
National Health and Nutrition Examination Survey, 1988-1991. Hypertension.
Butt, D. A., Mamdani, M., & Austin, P. C. (2012). The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. Calhoun, D. A., Jones, D., & Textor, S. (2008). Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension.
Chaudhry, S. I., Krumholz, H. M., & Foody, J. M. (2004). Systolic hypertension in older persons. JAMA.
Chobanian, A. V. (2007). Clinical practice. Isolated systolic hypertension in the elderly. N Engl J Med.
Chobanian, A. V., Bakris, G. L., & Black, H. R. (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA.
Duchier, J., Iannascoli, F., & Safar, M. (1987). Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol.
Egan, B. M., Zhao, Y., & Axon, R. N. (2010). US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA.
Egan, B. M., Zhao, Y., & Axon, R. N. (2011). Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation.
Forette, F., Seux, M. L., & Staessen, J. A. (1998). Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet.
Franklin, S. S., Gustin, W. 4., & Wong, N. D. (1997). Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation.
Franklin, S. S., Jacobs, M. J., & Wong, N. D. (2001). Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension.
Franklin, S. S., Larson, M. G., & Khan, S. A. (2001). Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation.
Franse, L. V., Pahor, M., & Di Bari, M. (2000). Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension.
Gangavati, A., Hajjar, I., & Quach, L. (2011). Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc.
Hansson, L., Lindholm, L. H., & Ekbom, T. (1999). Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet.
Izzo, J. L., Levy, D., & Black, H. R. (2000). Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension.
Jamerson, K., Weber, M. A., & Bakris, G. L. (2008). Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med.
Kannel, W. B. (1996). Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA.
Khan, N., & McAlister, F. A. (2006). Re-examining the efficacy of beta- blockers for the treatment of hypertension: a meta-analysis. CMAJ. Kostis, J. B., Davis, B. R., & Cutler, J. (1997). Prevention of heart failure by
antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA.
Law, M. R., Morris, J. K., & Wald, N. J. (2009). Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta- analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ.
Liu, L., Wang, J. G., & Gong, L. (1998). Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens.
Mancia, G., De Backer, G., & Dominiczak, A. (2007). Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J.
Messerli, F. H., Grossman, E., & Goldbourt, U. (1998). Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA.
Messerli, F. H., Mancia, G., & Conti, C. R. (2006). Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med.
Ministerio de Salud Pública del Ecuador. (2011). Protocolos clínicos y terapéuticos para la atención de las enfermedades crónicas no trasmisibles (diabetes 1, diabetes 2, dislipidemias, hipertensión arterial). Normatización del sistema nacional de salud programa del adulto-enfermedades crónicas no trans. Ministerio de Salud Pública del Ecuador.
MRC Working Party. (1992). Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ.
National High Blood Pressure Education Program Working Group. (1994). National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension.
National Institute for Health and Clinical Excellence. (2009, January 21). Hypertension: management of hypertension in adults in primary care
(NICE clinical guideline update). Retrieved from file://www.nice.org.uk
Neaton, J. D., & Wentworth, D. (1992). Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med.
Odden, M. C., Peralta, C. A., Haan, M. N., & Covinsky, K. E. (2012). Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med.
Ofili, E. O., Cohen, J. D., & St Vrainj., J. A. (1998). Effect of treatment of isolated systolic hypertension on left ventricular mass. JAMA.
Ostchega, Y., Dillon, C. F., & Hughes, J. P. (2007). Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc.
Pastor-Barriuso, R., Banegas, J. R., & Damián, J. (2003). Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med.
Protogerou, A. D., Safar, M. E., & Iaria, P. (2007). Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension.
Rosendorff, C., Black, R. R., & Cannon, C. P. (2007). Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Preventi. Circulation. SHEP Cooperative Research Group. (1991). Prevention of stroke by
antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA.
Somes, G. W., Pahor, M., & Shorr, R. I. (1999). The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med.
Staessen, J. A., Fagard, R., & Thijs, L. (1997). Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet.
Staessen, J. A., Fagard, R., & Thijs, L. (1998). Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med.
Staessen, J. A., Gasowski, J., & Wang, J. G. (2000). Risks of untreated and treated isolated systolic hyperten sion in the elderly: meta-analysis of outcome trials. Lancet.
Staessen, J. A., Richart, T., & Birkenhäger, W. H. (2007). Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension.
Staessen, J. A., Richart, T., & Verdecchia, P. (2008). Reducing blood pressure in people of different ages. BMJ.
Starmans-Kool, M. J., Kleinjans, H. A., & Lustermans, F. A. (1998). Treatment of elderly patients with isolated systolic hypertension with isosorbide dinitrate in an asymmetric dosing schedule. J Hum Hypertens.
Tuomilehto, J., Rastenyte, D., & Birkenhäger, W. H. (1999). Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med.
Vanhanen, h., Thijs , L., & Birkenhäger, W. (1996). Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hypertens.
Vasan, R. S., Beiser, A., & Seshadri, S. (2002). Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA.
Vasan, R. S., Larson, M. G., & Leip, E. P. (2001). Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet.
Velázquez, M. O., Rosas, P. M., Lara, E. A., & Pastelín, H. G. (2000). Hipertensión arterial Grupo ENSA 2000. México D.F.: Resultados de la Encuesta Nacional de Salud (ENSA).
Vokó, Z., Bots, M. L., & Hofman, A. (1999). J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension.
Whelton, P. K., Appel, L. J., & Espeland, M. A. (1998). Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. Wing, L. M., Reid, C. M., & Ryan, P. (2003). A comparison of outcomes with
angiotensin-converting--enzyme inhibitors and diuretics for
hypertension in the elderly. N Engl J Med.
Wright, J. T., Probstfield, J. L., & Cushman, W. C. (2009). ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Arch Intern Med.
Young, J. H., Klag, M. J., & Muntner, P. (2002). Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol.
Zanchetti, A., Grassi, G., Mancia , & Mancia, G. (2009). When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens.
Anexo Nº 1. Formato de la Ficha para la Recolección de Datos
FICHA DE RECOLECCIÓN DE DATOS
Nombre: _____________________________ HCL/ CI: ____________ Intervalo de edad 1.- 18 a 24 años 3.- 35 a 44 años 5.- 55 a 64 años 2.- 25 a 34 años 4. 45 a 54 años 6.- 65 a 70 años Género 1.- Masculino 2.- Femenino Colesterol > 200 mg dl 1.- SI 2.- NO TA sistólica > de 140 mmHg 1.- SI 2.- NO Tabaquismo 1.- SI 2.- NO Glicemia en ayuno > 126 mg dl 1.- SI 2.- NO Triglicéridos > 150 mg dL 1.-SI 2.- NO Insuficiencia Cardiaca 1.-SI 2.- NO
Eventos cardiovasculares ACV Isquémico Hemorrágico TEP AIT SCA
Fecha del primer evento Fecha del último evento
TERAPIA IECA ARA II DIURÉTICOS CALCIOANTAGONISTAS BETA BLOQUEANTES TERAPIA COMBINADA